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Abstract
Although hepatocellular function is depressed early after trauma and hemorrhage which are associated with low flow
.conditions and tissue hypoxemia , it remains unknown whether hypoxemia without blood loss, produces hepatocellular
dysfunction and, if so, whether IL-6 and PGE are associated with this dysfunction. To study this, rats were placed in a2
plastic box which was flushed with a gas mixture containing 6.3% O :93.7% N or room air for 60 min, followed by their2 2
return to room air. At 0 and 4 h after hypoxemia, hepatocellular function i.e., maximum velocity of indocyanine green
 .  ..clearance V and the efficiency of the transport K was measured using an in vivo hemoreflectometer. Cardiacmax m
output was assessed by dye dilution technique. Tissue microvascular blood flow was determined by laser Doppler
flowmetry. Plasma IL-6 and PGE were measured by bioassay and radioimmunoassay, respectively. The results indicate2
 .that hypoxemia produced a depression in hepatocellular function i.e., decreased V by 44–50% and K by 55–68%max m
despite stable cardiac output and hepatic microcirculation at 0 and 4 h after hypoxemia. Moreover, hypoxemia resulted in a
 .  .significant increase in plasma IL-6 by 372%–389% as well as PGE by 38% at 0 h post-hypoxemia . Thus, hypoxemia2
observed after trauma and hemorrhagic shock appears to be responsible for producing hepatocellular dysfunction possibly
through the up-regulation of IL-6 and PGE . In view of this, long-lasting hypoxemia in trauma victims should be avoided,2
perhaps by early intubation and ventilation so that the potential additional proinflammatory cytokine and PGE release can2
be prevented.
Keywords: Cardiac output; Microvascular blood flow; Indocyanine green clearance; Shock; Laser Doppler flowmetry; Proinflammatory
cytokine; Prostaglandin
1. Introduction
Trauma and hemorrhagic shock with the subse-
quent immune depression continue to be one of the
major causes of morbidity and mortality in the surgi-
w xcal intensive care unit 1,2 . In the patients who
survive the initial trauma and hemorrhagic episode,
) Corresponding author. Fax: q1 401 4443278.
there is an increased risk of the occurrence of sepsis,
w xmultiple organ failure, and late death 2,3 . In this
regard, rapid fluid replacement following trauma and
hemorrhagic shock plays an important role in de-
creasing the morbidity and mortality of such patients
w x4,5 . Although early and rapid fluid resuscitation
remains one of the major therapies in trauma and
hemorrhage victims, recent studies have indicated
that acute crystalloid resuscitation alone does not
w xrestore or maintain hepatocellular function 6 , tissue
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w x w xmicrovascular blood flow 7 , cardiac output 8 , or
w xglomerular filtration rate 9 following trauma and
severe hemorrhage. The fact that hemorrhage-induced
hepatocellular dysfunction persists despite acute fluid
resuscitation suggests that the eventsrmediators re-
sponsible for hepatocellular dysfunction cannot be
corrected with crystalloid resuscitation alone. Thus,
understanding of the mechanisms responsible for
hepatocellular dysfunction appears to be extremely
important in order to develop more rational therapies
for improving cell and organ function following
trauma-hemorrhage and resuscitation.
Studies have indicated that the decreased tissue
perfusion during hemorrhagic shock significantly re-
duces tissue oxygenation as well as the removal of
w xwaste products 10,11 . Moreover, postoperative hy-
poxemia may be associated with cell and organ dys-
w xfunction after major operations 12 . Tissue hypox-
emia following hemorrhagic shock plays a major role
in producing the alterations in cell and organ
w xmetabolisms 13 . Studies in the rat indicated that
after 120 min of exposure to low oxygen, tissue ATP
w xlevels decreased significantly 13 . Recent studies
have shown that hypoxemia in the mouse signifi-
cantly increased circulating levels of TNF-a and IL-6
as well as the release of TNF-a , IL-1b and IL-6 by
w xperitoneal macrophages and Kupffer cells 14 . Thus,
hypoxemia induces the release of proinflammatory
cytokines which may contribute to systemic inflam-
mation following hypoxemia as well as hemorrhagic
w xshock 14 . Although our previous studies have indi-
cated that hepatocellular function is depressed early
w xfollowing trauma and hemorrhagic shock 6 , it re-
mains unknown whether hypoxemia, in the absence
of blood loss, produces hepatocellular dysfunction
and, if so, whether IL-6 and PGE are associated2
with this dysfunction. Thus, the present study was
undertaken to determine whether or not hypoxemia
depresses hepatocellular function and up-regulates
IL-6 andror PGE .2
2. Materials and methods
2.1. Hypoxemia procedure
Hypoxemia was induced in the rat according to the
w xprocedure described by Ertel et al. 14 with some
modification. Male Sprague-Dawley rats Charles
River Laboratory, Wilmington, MA, weighing 275–
.  .325 g were fasting overnight ;16 h before the
experiment, but were allowed water ad libitum. After
methoxyflurane anesthesia, a femoral artery was can-
 .nulated with polyethylene PE -50 tubing for mea-
 .surement of mean arterial pressure MAP and heart
 .rate HR . The incision was sutured and bathed with
1% lidocaine in order to provide analgesia throughout
the experiment. Following blood vessel cannulation,
the animals were allowed to awaken. MAP and HR
were monitored by attaching the femoral catheter to a
strain gauge pressure transducer Model P23XL,
.Viggo-Spectramed, Oxnard, CA coupled to a poly-
graph Model 7D, Grass Instrument Co., Quincy,
.  .MA . A plastic box 22=23=30 cm with an inlet
and outlet, through which the hypoxic gas mixture or
room air flowed, was used. Hypoxemia was induced
by flushing the plastic box with a gas mixture of
6.3% O : 93.7% N at a flow rate of ;5 Lrmin via2 2
a bottle containing distilled water. The animals were
kept under the hypoxic condition for 60 min, fol-
lowed by return of the rats to room air. The average
MAP was 77–80 mmHg and Po was 35–40 mmHg2
 .during hypoxemia period. Sham control animals
underwent the same anesthesia and surgical proce-
dure, but the box was flushed with room air for 60
min at a flow rate of ;5 Lrmin. Measurements of
cardiac output, hepatocellular function and microvas-
cular blood flow in various organs were performed
 .immediately 0 h post-hypoxemia as well as at 4 h
after the completion of hypoxemia. Blood samples
were also collected at 0 and 4 h after hypoxemia.
There were 6–7 rats in each group at each time point,
and none of the animals died during the experiments.
The rats were killed by an overdose of intravenous
sodium pentobarbital at the end of each experiment.
All animal experiments were carried out according to
the guidelines set forth by the Animal Welfare Act
and The Guide for Care and Use of Laboratory
Animals, National Institutes of Health. This project
was approved by the Institutional Animal Care and
Use Committee of Rhode Island Hospital.
2.2. Determination of hepatocellular function
At 0 or 4 h after the completion of hypoxemia,
hepatocellular function i.e., the maximal velocity
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 .  .V and the transport efficiency K of indocya-max m
 . .nine green ICG clearance was assessed by using an
in vivo ICG clearance technique, as described previ-
w xously 6 . Briefly, the left carotid artery was isolated
under methoxyflurane anesthesia and a 2.4 French
fiber-optic catheter Hospex Fiberoptics, Chestnut
.Hill, MA was passed via the carotid artery to the
level of the aortic arch for continuous measurement
of ICG concentration using an in vivo hemoreflec-
 .tometer Hospex Fiberoptics . The right jugular vein
was cannulated with PE-50. Three separate doses
0.167, 0.333, and 0.833 mgrkg body wt. in 0.05 ml
. solutions each of ICG Cardio-Green, Becton Dick-
.inson, MD were then administered via the right
jugular catheter to the level of the right atrium for the
measurement of hepatocellular function. The concen-
tration of ICG was recorded every second for 5 min
with a computer-assisted data acquisition Asystant
.q , Asyst Software, Rochester, NY . As described
w xpreviously 6 , an ‘e’ raised to a second-order polyno-
mial was employed to determine the relationship
between ICG concentration and time. The calculation
of V and K was performed according to ourmax m
w xprevious publication 6,15 . Since any movement of
the rat may affect cardiac output measurement,
 .sodium pentobarbital ;15 mgrkg body wt. was
given intravenously in order to provide anesthesia to
the animals during the period of measurement.
2.3. Measurement of cardiac output
 .Cardiac output CO was determined by using an
ICG dilution technique with a fiber-optic catheter and
w xan in vivo hemoreflectometer 8 . After cannulation
of the left carotid artery with the 2.4 French fiber-optic
 .catheter, 0.05 mg of ICG in 0.05 ml solutions per
rat was administered via the jugular venous catheter.
With the aid of computer-assisted data acquisition, 20
ICG concentration points were recorded each second
for ;30 sec immediately after ICG solution injec-
tion. The area under the curve was calculated and CO
 .mlrminr100 g body wt. was determined according
to the principles of dye dilution.
2.4. Assessment of micro˝ascular blood flow
 .Microvascular blood flow MBF on the surface of
the liver, kidney, spleen, and small intestine was
w xdetermined by laser Doppler flowmetry 7 at 0 or 4 h
after hypoxemia. Briefly, a 5-cm abdominal incision
was performed under methoxyflurane anesthesia and
a laser Doppler blood perfusion monitor Laserflo,
.Model BPM 403A, TSI, St. Paul, MN with a needle
flow probe was used. The probe was placed on the
surface of tested organs, and three measurements of
each organ were averaged. The measured MBF was
the microvascular red blood cell flux in ;1 mm3 on
the surface of each organ with a unit of mlrmin per
100 g tissue, as indicated by the manufacturer. Al-
though this is a reliable technique for determining the
alterations of organ surface perfusion, the manufac-
turer-suggested flow unit should be considered as
arbitrary rather than absolute units.
2.5. Assays for plasma IL-6
 .Blood samples ;0.5 ml were drawn from the
femoral arterial catheter into a heparinized syringe at
0 or 4 h after the completion of hypoxemia. The
plasma was immediately separated by centrifugation
at 12 000=g for 15 min at 48C, aliquoted, and stored
at y708C until assayed. As described previously
w x16 , IL-6 activity was determined by using the IL-6
dependent 7TD1 B-cell hybridoma. It should be
pointed out that the cytokine assay has been shown to
w xreact in a specific fashion to IL-6 17 .
2.6. Determination of plasma PGE le˝els2
Prostaglandin E levels in plasma were measured2
using a radioimmunoassay technique Prostaglandin
w125 xE I RIA Kit, NEN-DuPont; cross-reactivity with2
PGE : 3.7%, DHKPGE : 0.4%, PGA : 0.4%, other1 2 2
.prostaglandins and arachidonic acid: -0.01% ac-
cording to the manufacturer’s guidelines. Blood sam-
 .ples 1 ml each were collected in prechilled
polypropylene test tubes coated with a solution of 4.5
mM EDTA and 10 mgrml indomethacin at 0 or 4 h
after the completion of hypoxemia. The plasma frac-
tion was separated and frozen at y708C until as-
sayed. Prostaglandins, therefore, were extracted and
purified from plasma using absorption and elution
from Bond-Elut C and SI columns Analytichem18
.International, Harbor City, CA before assaying
w xPGE , as described previously 18 . The recovery of2
the extraction procedure, as well as the assay, was
more than 90%.
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2.7. Statistical analysis
All data are expressed as mean"S.E.M. One-way
 .analysis of variance ANOVA and Tukey’s test were
employed, and the differences were considered signif-
icant at P value F0.05.
3. Results
3.1. Effects of hypoxemia on mean arterial pressure,
heart rate, cardiac output and micro˝ascular blood
flow
The results in Fig. 1A indicate that MAP de-
creased by ;30% from pre-hypoxemia level of 111
 .mmHg P-0.05 at 10 min after the onset of hypox-
emia. The average MAP was 77–80 mmHg over 60
 .min of hypoxemia period Fig. 1A . At 5 min after
the completion of hypoxemia, however, MAP in-
creased to 105"2 mmHg. Moreover, at 4 h after
hypoxemia MAP was not different from the pre-hy-
 .Fig. 1. A. Changes in mean arterial pressure MAP prior to,
during and following 60-min hypoxemia. There were six to seven
animals in this portion of the experiment. The hypoxemia proce-
dure and MAP measurement are described in Section 2. Data are
presented as mean"S.E.M. and compared by one-way ANOVA
and Tukey’s test. )P -0.05 as compared with the pre-hypoxemia
 .value. B. Changes in heart rate HR prior to, during and
 .following 60-min hypoxemia. See legend for A for further
details.
Table 1
 .Alterations in cardiac output CO, mlrmin per 100 g body wt.
 .and microvascular blood flow MBF, arbitrary unit at 0 and 4 h
after 60-min hypoxemia
Sham- 0 h post- 4 h post-
operated hypoxemia hypoxemia
CO 30.5"1.35 31.7"0.56 31.2"0.84
Hepatic MBF 40.4"2.7 37.4"1.5 36.2"4.7
Renal MBF 97.4"1.2 97.0"4.1 100.2"3.3
Splenic MBF 34.8"2.8 39.0"4.5 33.5"4.5
Intestinal MBF 109.2"2.0 107.9"4.2 105.2"4.4
Data are presented as mean"S.E.M. and one-way analysis of
 .variance ANOVA indicated that there was no significant differ-
ence between groups in all the measured parameters. There were
six to seven animals in each group.
 .poxemia level Fig. 1A . Thus, moderate hypotension
occurred only during 60-min hypoxic period. In con-
trast to MAP, heart rate was not significantly altered
 .during and following hypoxemia Fig. 1B . Cardiac
output and MBF in the liver, kidney, spleen and
 .Fig. 2. A. Changes in maximal velocity V of indocyaninemax
green clearance in sham animals and at 0 and 4 h after the
completion of hypoxemia. There were six to seven animals in
each group at each time point. The hypoxemia procedure and
hepatocellular function measurement are described in Section 2.
Data are presented as mean"S.E.M. and compared by one-way
ANOVA and Tukey’s test. )P -0.05 as compared with sham
 .value. B. Changes in the efficiency K of the indocyaninem
green transport in sham animals and at 0 and 4 h after the
 .completion of hypoxemia. See legend for A for further details.
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small intestine were not significantly different from
shams at 0 as well as 4 h after the completion of
 .hypoxemia Table 1 .
3.2. Effects of hypoxemia on hepatocellular function
As shown in Fig. 2A, V value was 1.18"0.13max
 .mgrkg per min in sham control animals. In the rats
subjected to hypoxemia, V decreased by 44% Pmax
.  .-0.05 and 50% P-0.05 at 0 and 4 h after the
completion of hypoxemia, respectively. Similarly, Km
 .  .decreased by 55% P-0.05 and 68% P-0.05 at
0 and 4 h after hypoxemia, respectively, compared
 .with sham-operated animals Fig. 2B .
3.3. Effects of hypoxemia on plasma IL-6 and PGE2
le˝els
In sham animals, plasma levels of IL-6 were 18.7
 ."6.1 Urml and it increased by 372% P-0.05
 .and 389% P-0.05 at 0 and 4 h after the comple-
 .tion of hypoxemia, respectively Fig. 3A . Although
plasma levels of PGE increased significantly imme-2
 .Fig. 3. A. Changes in plasma levels of interleukin-6 IL-6 in
sham animals and at 0 and 4 h after the completion of hypox-
emia. There were six to seven animals in each group at each time
point. The hypoxemia procedure and IL-6 assay are described in
Section 2. Data are presented as mean"S.E.M. and compared by
one-way ANOVA and Tukey’s test. )P -0.05 as compared with
sham value. B. Changes in plasma levels of prostaglandin E2
 .PGE in sham animals and at 0 and 4 h after the completion of2
 .hypoxemia. See legend for A for further details.
diately after hypoxemia increased by 38%, P-
.0.05 , such an elevated level of PGE was not sus-2
tained and it returned to sham levels at 4 h after
 .hypoxemia Fig. 3B .
4. Discussion
Despite the fact that fluid replacement has been
widely used for the management of the victims of
trauma and hemorrhagic shock, our recent studies
have indicated that acute crystalloid resuscitation
alone does not restore hepatocellular and cardio-
w x w xvascular function 6,8 , renal function 9 , or vascular
w xand liver endothelial cell function 19,20 following
trauma and severe hemorrhage. It has been shown
that the reduced microvascular blood flow observed
in multiple organs during hemorrhagic shock re-
mained depressed even following crystalloid resusci-
w xtation 7 . This would suggest that low flow condi-
tions and subsequent tissue hypoxemia persist despite
the acute fluid resuscitation after trauma and hemor-
rhage. Such an alteration in tissue oxygenation in-
duced by the depressed microcirculation may result
in cell and organ dysfunction following trauma-hem-
orrhage and resuscitation. However, it remains un-
known whether actual blood loss or hypoxemia even
in the absence of blood loss produces cell dysfunc-
tion. Therefore, the present study was undertaken to
determine whether or not hypoxemia, in the absence
of any blood loss, produces hepatocellular dysfunc-
tion and, if so, whether proinflammatory cytokine
IL-6 as well as PGE are associated with the occur-2
rence of hepatocellular dysfunction.
The results of this study indicate that 60-min
 .hypoxia 6.3% O : 93.7% N produced a marked2 2
depression in hepatocellular function as evidenced by
44–50% decrease in V and 55%–68% decrease inmax
K values immediately following hypoxemia as wellm
as at 4 h after the completion of hypoxemia. Hepato-
cellular dysfunction occurred despite the stable car-
diac output and hepatic microvascular blood flow at 0
and 4 h after hypoxemia. It should be pointed out that
ICG clearance is a very sensitive measure of hepato-
cellular function since ICG clearance is altered earlier
than the increase in circulating levels of liver en-
w xzymes such as SGPT and SGOT 21 . Although it is
not known whether cardiac output and hepatic perfu-
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sion decrease during the course of hypoxemia, the
above results clearly indicate that hepatocellular dys-
function observed following hypoxemia is not due to
any depression in hepatic perfusion or cardiac output
at the above-mentioned time points. In addition, hy-
poxemia resulted in a significant increase in plasma
levels of proinflammatory cytokine IL-6 as well as
PGE . These results would indicate that hypoxemia2
observed after trauma and hemorrhagic shock appears
to be responsible for producing hepatocellular dys-
function. In a mouse hypoxemia model 5% O :95%2
.N for 60 min , Ertel et al. have demonstrated that2
hypoxemia produced an increase in circulating levels
w xof TNF 14 . In this regard, studies by Wibbenmeyer
et al. have shown that hypoxia and reoxygenation
increase TNF-a release without up-regulating TNF-a
w xmRNA in a perfused liver preparation 22 . In the
present study, circulating levels of IL-6 and PGE2
increased significantly after hypoxemia. These re-
sults, taken together, would suggest that up-regu-
 .lation of proinflammatory cytokines TNF and IL-6
as well as PGE productionrrelease during hypox-2
emia may be responsible for producing hepatocellular
dysfunction observed under such conditions.
Our results of decreased ICG clearance following
hypoxemia are in agreement with the study of Black-
w xmon and Rowell 23 who showed that in humans,
ICG extraction was significantly reduced without a
significant decrease in the clearance of norepineph-
w xrine and epinephrine following hypoxemia 23 . Other
aspects of hepatocellular function are also affected by
in vivo hypoxia. For example, hepatic gluconeogene-
sis is inhibited following hypoxemia by decreasing
phosphoenolpyruvate carboxykinase gene transcrip-
w xtion 24 . In addition, mediatorsragents released by
liver endothelial cells or Kupffer cells may contribute
to the development of hepatocellular dysfunction dur-
ing either hypoxemia or reoxygenation by different
mechanisms. It has been reported that sinusoidal
endothelial cells respond to the hypoxic phase by
producing oxygen-derived free radicals and that
Kupffer cells respond to the subsequent reoxygena-
tion phase by activation followed by the release of
w xvarious inflammatory mediators 25 . Moreover, it
has been demonstrated that hypoxemia increases the
number of whole blood polymorphonuclear leuko-
w xcytes for enhanced phagocytosis 26 .
Although cardiac output was not significantly al-
tered at 0 and 4 h after the completion of hypoxemia
in the present study, studies by Phillips et al. indicate
that cardiac output increased in response to acute
w xisocapnic hypoxemia in normal human subject 27 .
The difference between the present study and their
studies may be simply due to the fact that much less
 .severe hypoxemia oxygen saturation of 80%–90%
w xwas induced in the study by Phillips et al. 27 . Our
previous study in mice using a similar model of
hypoxemia and the current study have shown that
despite an approximately 75% decrease in arterial
Po , mean arterial pressure only decreased by 15%–2
w x30% during hypoxemia 14 . In view of the above
information, it appears unlikely that severe reduction
in cardiac output occurs during the course of hypox-
emia in the present study. It could be argued, how-
ever, that the hepatocellular dysfunction observed
following hypoxemia is due to the decreased oxygen
availability. Although this may be the case, studies
have indicated that hepatic oxygenation in the neonate
as well as in the adult, is dependent on total hepatic
w xperfusion rather than adequate oxygen supply 28 .
This is supported by the fact that despite reduction in
oxygen delivery of up to 50%, hepatic oxygen con-
sumption did not fall because hepatic oxygen extrac-
w xtion increased as a compensatory mechanism 28 .
However, it remains to be determined at what extent
reoxygenation injury contributes to hepatocellular
dysfunction observed in the present study.
In summary, our results indicate that hypoxemia
resulted in a significant depression in hepatocellular
function at 0 and 4 h after the completion of hypox-
emia, as evidenced by decreased ICG clearance. Hep-
atocellular dysfunction occurred despite the fact the
cardiac output and hepatic microcirculation was not
significantly different from sham-operated animals
under such conditions. In addition, hypoxemia in-
creased circulating levels of proinflammatory cy-
tokine IL-6 as well as PGE . These results lead us to2
conclude that hypoxemia observed after trauma and
hemorrhagic shock appears to be responsible for pro-
ducing hepatocellular dysfunction possibly via the
up-regulation of the production andror release of
IL-6 and PGE . In view of this, long-lasting hypox-2
emia in trauma victims should be avoided, perhaps by
early intubation and ventilation so that the potential
additional proinflammatory cytokine and PGE re-2
lease can be prevented.
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